Hamburg - IDEX Health & Science today announ­ced the acqui­si­tion of thinXXS Micro­tech­no­logy AG. The acqui­si­tion is expec­ted to acce­le­rate growth in the micro­flui­dics consu­ma­bles busi­ness. The share­hol­ders of thinXXS Micro­tech­no­logy AG, inclu­ding the majo­rity share­hol­der PRICAP Venture Part­ners AG, were advi­sed by Heuking Kühn Lüer Wojtek on the sale of their shares to a subsi­diary of IDEX Corpo­ra­tion. The parties have agreed not to disc­lose the purchase price.

thinXXS Micro­tech­no­logy, based in Zwei­brü­cken, Germany, is a leading company in the deve­lo­p­ment and manu­fac­ture of plas­tic disposable systems for the life scien­ces, point-of-care and vete­ri­nary markets. The acqui­si­tion estab­lishes IDEX Health & Science as a tech­no­logy leader in micro­flui­dics and streng­thens its growth focus on inte­gra­ted opto­flui­dic systems, compon­ents and advan­ced solu­ti­ons for its target industries.

Advi­sors to thinXXS Micro­tech­no­logy AG: Heuking Kühn Lüer Wojtek
Part­ner Dr. Michael Dröge, Part­ner Julia Cramer (both lead and M&A/Corporate), Fabian G. Gaffron (Tax), all Hamburg
Dr. Thors­ten Kuthe (Stock Corpo­ra­tion Law), Cologne
Dr. Frede­rik Wiemer (Anti­trust Law)
Dr. Florian Wenk, LL.M. (Corpo­rate Law)
Dr. Chris­tina Etzel,
Sven Johann­sen (both Vendor Due Dili­gence), all Hamburg